Works matching DE "ROMIPLOSTIM"
Results: 60
Efficacy of romiplostim in the treatment of ITP in children: a meta-analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2018, v. 22, n. 18, p. 6162
- By:
- Publication type:
- Article
The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 5, p. 837, doi. 10.3390/biom13050837
- By:
- Publication type:
- Article
Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use.
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 1237, doi. 10.2147/PPA.S192481
- By:
- Publication type:
- Article
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia.
- Published in:
- Expert Review of Clinical Immunology, 2022, v. 18, n. 8, p. 783, doi. 10.1080/1744666X.2022.2098119
- By:
- Publication type:
- Article
Safety and Efficacy of Eltrombopag and Romiplostim in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.582686
- By:
- Publication type:
- Article
Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.019
- By:
- Publication type:
- Article
Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.021
- By:
- Publication type:
- Article
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune Thrombocytopenia.
- Published in:
- Clinical Pharmacology in Drug Development, 2025, v. 14, n. 2, p. 116, doi. 10.1002/cpdd.1494
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Pharmacodynamics of Romiplostim in Chinese Subjects With Immune Thrombocytopenia: A Phase I/II Trial.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 3, p. 379, doi. 10.1002/cpdd.1059
- By:
- Publication type:
- Article
Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 10, p. 2499, doi. 10.1080/10428194.2022.2074992
- By:
- Publication type:
- Article
Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies.
- Published in:
- Platelets, 2022, v. 33, n. 8, p. 1312, doi. 10.1080/09537104.2022.2117293
- By:
- Publication type:
- Article
Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description.
- Published in:
- Platelets, 2020, v. 31, n. 3, p. 403, doi. 10.1080/09537104.2019.1615613
- By:
- Publication type:
- Article
Developmental differences between newborn and adult mice in response to romiplostim.
- Published in:
- Platelets, 2018, v. 29, n. 4, p. 365, doi. 10.1080/09537104.2017.1316481
- By:
- Publication type:
- Article
Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia.
- Published in:
- Platelets, 2012, v. 23, n. 4, p. 264, doi. 10.3109/09537104.2011.619601
- By:
- Publication type:
- Article
An Analysis of the Serum Metabolomic Profile for the Radiomitigative Effect of the Thrombopoietin Receptor Agonist Romiplostim in Lethally Whole-Body-Irradiated Mice.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/metabo12020161
- By:
- Publication type:
- Article
Controlling for Differential Regression-To-The-Mean via Propensity Scores: A Simulation Study.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 661, doi. 10.2147/CLEP.S406552
- By:
- Publication type:
- Article
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 503, doi. 10.1111/bjh.15803
- By:
- Publication type:
- Article
Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Romiplostim for the management of perioperative thrombocytopenia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 1, p. 106, doi. 10.1111/bjh.15280
- By:
- Publication type:
- Article
The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 6, p. 991, doi. 10.1111/bjh.14024
- By:
- Publication type:
- Article
Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 1, p. 111, doi. 10.1111/bjh.13266
- By:
- Publication type:
- Article
Romiplostim for management of chemotherapy-induced thrombocytopenia.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 5, p. 1217, doi. 10.1007/s00520-013-2074-2
- By:
- Publication type:
- Article
Protein Expression and Purification of Romiplostim and Analysis of Its Secretory Production Using an In Silico Investigated Signal Peptide in E. Coli.
- Published in:
- Reports of Biochemistry & Molecular Biology, 2023, v. 12, n. 1, p. 27
- By:
- Publication type:
- Article
Proteomic changes by radio-mitigative thrombopoietin receptor agonist romiplostim in the blood of mice exposed to lethal total-body irradiation.
- Published in:
- International Journal of Radiation Biology, 2020, v. 96, n. 9, p. 1125, doi. 10.1080/09553002.2020.1787546
- By:
- Publication type:
- Article
Romiplostim (NplateVR) as an effective radiation countermeasure to improve survival and platelet recovery in mice.
- Published in:
- International Journal of Radiation Biology, 2020, v. 96, n. 1, p. 145, doi. 10.1080/09553002.2019.1605465
- By:
- Publication type:
- Article
Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data.
- Published in:
- Current Medical Research & Opinion, 2024, v. 40, n. 5, p. 781, doi. 10.1080/03007995.2024.2328653
- By:
- Publication type:
- Article
Missing Cells - A Rare Case of Persisting Thrombocytopenia in Pregnancy With Dengue and Role of Romiplostim in These Cases.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Romiplostim in the management of the thrombocytopenic surgical patient.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Sustained Remission Off-Treatment (SROT) of TPO-RAs: The Burgos Ten-Step Eltrombopag Tapering Scheme.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 4, p. 659, doi. 10.3390/medicina59040659
- By:
- Publication type:
- Article
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia.
- Published in:
- ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 715, doi. 10.2147/CEOR.S177338
- By:
- Publication type:
- Article
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia.
- Published in:
- ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 705, doi. 10.2147/CEOR.S177324
- By:
- Publication type:
- Article
Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 344, doi. 10.3390/pharmaceutics15020344
- By:
- Publication type:
- Article
Effect of Thrombopoietin Receptor Agonist on Pregnant Mice.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 3, p. 514, doi. 10.3390/pharmaceutics14030514
- By:
- Publication type:
- Article
Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 9, p. 1215, doi. 10.3390/ph16091215
- By:
- Publication type:
- Article
The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 868, doi. 10.3390/ph16060868
- By:
- Publication type:
- Article
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 5, p. 423, doi. 10.1111/ejh.12181
- By:
- Publication type:
- Article
Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?
- Published in:
- Folia Medica Indonesiana, 2015, v. 51, n. 3, p. 203
- By:
- Publication type:
- Article
The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia - a single center experience.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2022, v. 79, n. 10, p. 958, doi. 10.2298/VSP210721090V
- By:
- Publication type:
- Article
Avatrombopag v léčbě trombocytopenií – lékový profi l přípravku Doptelet.
- Published in:
- Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2023, v. 29, n. 4, p. 267
- Publication type:
- Article
Doporučení České hematologické společnosti pro diagnostiku a léčbu imunitní trombocytopenie dospělých.
- Published in:
- Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2023, v. 29, n. 1, p. 68
- By:
- Publication type:
- Article
Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Controlled Study.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 3, p. 173, doi. 10.1159/000528642
- By:
- Publication type:
- Article
Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 4, p. 394, doi. 10.1159/000521689
- By:
- Publication type:
- Article
Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes.
- Published in:
- Journal of Veterinary Internal Medicine, 2024, v. 38, n. 4, p. 2158, doi. 10.1111/jvim.17131
- By:
- Publication type:
- Article
Uso de romiplostim en trombocitopenia inmunitaria: experiencia en Cuenca (Ecuador).
- Published in:
- Biomédica: Revista del Instituto Nacional de Salud, 2024, v. 44, p. 198, doi. 10.7705/biomedica.7059
- By:
- Publication type:
- Article
Treatment of 5 dogs with immunemediated thrombocytopenia using Romiplostim.
- Published in:
- BMC Veterinary Research, 2016, v. 12, p. 1, doi. 10.1186/s12917-016-0718-4
- By:
- Publication type:
- Article
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2895, doi. 10.1007/s00277-023-05410-3
- By:
- Publication type:
- Article
Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2143, doi. 10.1007/s00277-021-04590-0
- By:
- Publication type:
- Article